These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202 [TBL] [Abstract][Full Text] [Related]
3. Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys. Sun C; Chen Z; Tang X; Zhang Y; Feng L; Du Y; Xiao L; Liu L; Zhu W; Chen L; Zhang L J Virol; 2013 May; 87(10):5669-77. PubMed ID: 23487457 [TBL] [Abstract][Full Text] [Related]
4. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV. Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132 [TBL] [Abstract][Full Text] [Related]
5. Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys. Wilks AB; Christian EC; Seaman MS; Sircar P; Carville A; Gomez CE; Esteban M; Pantaleo G; Barouch DH; Letvin NL; Permar SR J Immunol; 2010 Dec; 185(11):7097-106. PubMed ID: 21041730 [TBL] [Abstract][Full Text] [Related]
6. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187 [TBL] [Abstract][Full Text] [Related]
7. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694 [TBL] [Abstract][Full Text] [Related]
8. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys. Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518 [TBL] [Abstract][Full Text] [Related]
9. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. Kawada M; Tsukamoto T; Yamamoto H; Iwamoto N; Kurihara K; Takeda A; Moriya C; Takeuchi H; Akari H; Matano T J Virol; 2008 Oct; 82(20):10199-206. PubMed ID: 18667518 [TBL] [Abstract][Full Text] [Related]
10. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Stittelaar KJ; Gruters RA; Schutten M; van Baalen CA; van Amerongen G; Cranage M; Liljeström P; Sutter G; Osterhaus AD Vaccine; 2002 Jul; 20(23-24):2921-7. PubMed ID: 12126903 [TBL] [Abstract][Full Text] [Related]
12. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159 [TBL] [Abstract][Full Text] [Related]
14. T-cell vaccination could reduce SIV viral load in semen of rhesus monkeys. Immunotherapy; 2010 Jan; 2(1):6. PubMed ID: 20635885 [No Abstract] [Full Text] [Related]
15. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249 [TBL] [Abstract][Full Text] [Related]